Renal Fanconi syndrome with meropenem-containing regimen in drug-resistant tuberculosis

Affiliations

• ¹ Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University, London, UK.
• ² Division of Infection, Royal London Hospital, Barts Health NHS Trust, London, UK.
• ³ These authors contributed equally.
• ⁴ Division of Infectious Diseases, CHU Saint-Pierre, Université Libre de Bruxelles (ULB), Brussels, Belgium.
• ⁵ Clinical Epidemiology and Medical Statistics Unit, Dept of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy.
• ⁶ World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Maugeri Care and Research Institute, Tradate, Italy.
• ⁷ Public Health Consulting Group, Lugano, Switzerland.
• ⁸ University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands.
• ⁹ World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Maugeri Care and Research Institute, Tradate, Italy [email protected].